Colin Watts
Editor
2013
The clinical and scienti fi c fi eld of neuro-oncology is one of the most exciting and rapidly changing areas of oncology. The heterogeneity of glial cancers is being addressed at the level of molecular genetics and gene expression pro fi ling. This is paving the way for functionalizing the genome and individualizing therapy for patients. The cell biology of glial cancers is in hot pursuit as our understanding of glial ontogeny and function enters a new era and the lessons begin to percolate translational science.